BOSTON OMAHA CORP-CL A (BOC) Fundamental Analysis & Valuation

NYSE:BOC • US1010441053

Current stock price

12.22 USD
-0.08 (-0.65%)
At close:
12.22 USD
0 (0%)
After Hours:

This BOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BOC Profitability Analysis

1.1 Basic Checks

  • BOC had negative earnings in the past year.
  • In the past year BOC had a positive cash flow from operations.
  • In multiple years BOC reported negative net income over the last 5 years.
  • Of the past 5 years BOC 4 years had a positive operating cash flow.
BOC Yearly Net Income VS EBIT VS OCF VS FCFBOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

  • With a decent Return On Assets value of -0.03%, BOC is doing good in the industry, outperforming 69.57% of the companies in the same industry.
  • With a decent Return On Equity value of -0.04%, BOC is doing good in the industry, outperforming 71.74% of the companies in the same industry.
Industry RankSector Rank
ROA -0.03%
ROE -0.04%
ROIC N/A
ROA(3y)-0.02%
ROA(5y)1.3%
ROE(3y)-0.04%
ROE(5y)2.1%
ROIC(3y)N/A
ROIC(5y)N/A
BOC Yearly ROA, ROE, ROICBOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • BOC has a Gross Margin of 67.24%. This is amongst the best in the industry. BOC outperforms 84.78% of its industry peers.
  • BOC's Gross Margin has declined in the last couple of years.
  • BOC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y-1.7%
BOC Yearly Profit, Operating, Gross MarginsBOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BOC Health Analysis

2.1 Basic Checks

  • BOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BOC has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BOC has more shares outstanding
  • BOC has a worse debt/assets ratio than last year.
BOC Yearly Shares OutstandingBOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BOC Yearly Total Debt VS Total AssetsBOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BOC has an Altman-Z score of 1.43. This is a bad value and indicates that BOC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BOC (1.43) is better than 64.13% of its industry peers.
  • BOC has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • BOC's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. BOC outperforms 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.43
ROIC/WACCN/A
WACC8.44%
BOC Yearly LT Debt VS Equity VS FCFBOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 2.07 indicates that BOC has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.07, BOC is doing good in the industry, outperforming 76.09% of the companies in the same industry.
  • BOC has a Quick Ratio of 2.07. This indicates that BOC is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.07, BOC is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 2.07
BOC Yearly Current Assets VS Current LiabilitesBOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BOC Growth Analysis

3.1 Past

  • BOC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
  • Looking at the last year, BOC shows a small growth in Revenue. The Revenue has grown by 6.92% in the last year.
  • The Revenue has been growing by 21.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y23.87%
Revenue growth 5Y21.21%
Sales Q2Q%3.73%

3.2 Future

  • The Earnings Per Share is expected to decrease by -42.13% on average over the next years. This is quite bad
  • Based on estimates for the next years, BOC will show a small growth in Revenue. The Revenue will grow by 4.54% on average per year.
EPS Next Y-430.25%
EPS Next 2Y-42.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.05%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BOC Yearly Revenue VS EstimatesBOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
BOC Yearly EPS VS EstimatesBOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. BOC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Forward Price/Earnings Ratio is negative for BOC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BOC Price Earnings VS Forward Price EarningsBOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as BOC.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.01
BOC Per share dataBOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • BOC's earnings are expected to decrease with -42.13% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.13%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BOC Dividend Analysis

5.1 Amount

  • BOC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BOC Fundamentals: All Metrics, Ratios and Statistics

BOSTON OMAHA CORP-CL A

NYSE:BOC (3/17/2026, 7:02:31 PM)

After market: 12.22 0 (0%)

12.22

-0.08 (-0.65%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners65.07%
Inst Owner ChangeN/A
Ins Owners3.99%
Ins Owner Change0.82%
Market Cap384.32M
Revenue(TTM)112.60M
Net Income(TTM)-231.30K
Analysts45
Price Target14.28 (16.86%)
Short Float %5.1%
Short Ratio10.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-273.93%
Min EPS beat(2)-331.02%
Max EPS beat(2)-216.83%
EPS beat(4)1
Avg EPS beat(4)23.93%
Min EPS beat(4)-331.02%
Max EPS beat(4)941.58%
EPS beat(8)1
Avg EPS beat(8)-103.94%
EPS beat(12)3
Avg EPS beat(12)320.2%
EPS beat(16)3
Avg EPS beat(16)-316.28%
Revenue beat(2)0
Avg Revenue beat(2)-3.2%
Min Revenue beat(2)-5.02%
Max Revenue beat(2)-1.39%
Revenue beat(4)2
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)1.31%
Revenue beat(8)4
Avg Revenue beat(8)-0.6%
Revenue beat(12)7
Avg Revenue beat(12)0.23%
Revenue beat(16)9
Avg Revenue beat(16)0.79%
PT rev (1m)0%
PT rev (3m)-17.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.41
P/FCF N/A
P/OCF 18.05
P/B 0.73
P/tB 1.31
EV/EBITDA 13.01
EPS(TTM)0
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)0.68
OCFY5.54%
SpS3.58
BVpS16.8
TBVpS9.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.03%
ROE -0.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.24%
FCFM N/A
ROA(3y)-0.02%
ROA(5y)1.3%
ROE(3y)-0.04%
ROE(5y)2.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y-1.7%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 2.01
Cap/Depr 108.95%
Cap/Sales 24.67%
Interest Coverage N/A
Cash Conversion 95.49%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 2.07
Altman-Z 1.43
F-Score4
WACC8.44%
ROIC/WACCN/A
Cap/Depr(3y)225.08%
Cap/Depr(5y)197.89%
Cap/Sales(3y)44.31%
Cap/Sales(5y)37.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y-430.25%
EPS Next 2Y-42.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.92%
Revenue growth 3Y23.87%
Revenue growth 5Y21.21%
Sales Q2Q%3.73%
Revenue Next Year5.05%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y65.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year401.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.88%
OCF growth 3Y39.83%
OCF growth 5Y17.19%

BOSTON OMAHA CORP-CL A / BOC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BOSTON OMAHA CORP-CL A (BOC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BOC.


What is the valuation status for BOC stock?

ChartMill assigns a valuation rating of 0 / 10 to BOSTON OMAHA CORP-CL A (BOC). This can be considered as Overvalued.


What is the profitability of BOC stock?

BOSTON OMAHA CORP-CL A (BOC) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for BOC stock?

The Earnings per Share (EPS) of BOSTON OMAHA CORP-CL A (BOC) is expected to decline by -430.25% in the next year.